尿路結石症管理デバイス市場：デバイスタイプ、治療タイプ、デバイス材料、用途、エンドユーザー別-2025-2030年の世界予測

尿路結石症管理デバイス市場は、2024年には4億9,076万米ドルとなり、2025年には5億2,703万米ドル、CAGR7.73%で成長し、2030年には7億6,730万米ドルに達すると予測されています。

尿路結石管理機器の現在の状況は、急速な技術革新と変革の時代を迎えています。今日のヘルスケア環境では、技術の進歩により、腎結石、尿管結石、膀胱結石の治療において、より高い精度、効率性、安全性を提供する機器が開発されています。このダイナミックな分野では、最も一般的な尿路疾患の1つに対処するため、複雑な医療工学と進化する臨床実践が融合しています。

臨床医、生物医学エンジニア、病院管理者を含む利害関係者は、患者の転帰を改善するだけでなく、手技による合併症を軽減するソリューションを常に探し求めています。高度な画像診断、低侵襲的介入技術、および人間工学に基づいた機器の改良の統合は、結石管理における実践を劇的に変化させました。この進化は、内視鏡的アプローチと非侵襲的アプローチの両方を通じて尿路結石症を管理するために設計された最先端の機器によって、従来の方法が補完されたり、あるいは置き換えられたりするような、進歩的なシフトを意味しています。

このような環境では、専門家の見識とエビデンスに基づくデータが意思決定の指針となり、研究開発への投資が促進されます。技術革新が従来の方法を破壊し続ける中、臨床効果と技術的進歩の相互作用が将来の戦略のロードマップを定義します。臨床ワークフローと患者ケアの強化のためにこれらの改善を活用する機会は、これまで以上に顕著になっており、市場全体の見通しが有望であることを示しています。

尿路結石症市場を牽引する変革的シフト

近年、尿路結石管理機器市場を再定義する変革的なシフトが顕著です。技術革新のペースは、より効率的であるだけでなく、より安全で使いやすい機器の到来を告げています。技術革新は、画像技術の向上、ナビゲーション機能の強化、手術中のリアルタイムフィードバック機構につながっています。この進化の一因は、低侵襲手術、患者の快適性の向上、回復時間の短縮に対する需要の高まりにあります。

規制政策もまた進化しており、患者の安全性を最優先する一方で、革新的な医療機器の迅速な市場参入を促進しています。臨床医と技術専門家の共同作業により、尿路結石症治療の微妙な違いに合わせた機器の開発が進んでいます。ヘルスケアプロバイダーは現在、既存の病院インフラとシームレスに統合し、自動化とデジタル監視によって複雑な手順を簡素化する技術を採用する傾向が強まっています。

さらに市場では、従来の手術方法から、AIを活用した診断や手技ガイダンスを組み込んだデジタル技術への移行が徐々に進んでいます。研究開発への投資は、産業界がこれらの新しいデバイスの未開拓の可能性を認識するにつれて、着実に増え続けています。この情勢の変革は、イノベーションと実用的でエビデンスに基づく臨床成果を融合させる進化するエコシステムによって支えられています。臨床医と医療機器メーカーが相乗効果を発揮することで、治療成績の向上とコスト効率の改善が急速に現実のものとなりつつあります。

ディープダイブ市場セグメンテーション：デバイス、治療、材料、用途、エンドユーザーへの洞察

尿路結石管理デバイス市場を包括的に分析すると、市場ランドスケープの多様性を捉える複雑なセグメンテーション戦略が明らかになります。デバイスの種類に基づくセグメンテーションでは、市場をガイドワイヤー、砕石器、ステント、尿管鏡などのセグメントに分解し、それぞれが治療プロトコルで独自の役割を果たしています。治療タイプのレンズを通して市場を調査すると、体外衝撃波結石破砕術、体腔内結石破砕術、経皮的腎結石除去術が手技選択の最前線にあり、それぞれが侵襲性と回復時間に関して明確な利点を提供していることが明らかです。

この分析は、装置の材料に基づくセグメンテーションによってさらに充実しており、市場を金属ベースの装置とポリマーベースの装置に分類しています。この分類は、治療効果を左右する性能の違い、耐久性、患者固有の考慮事項の理解に役立ちます。さらに、アプリケーションベースの分類に注目することで、市場調査は膀胱結石、腎臓結石、尿管結石に関連する病態を取り上げ、それによって治療ニーズと手術の専門性を調整した見解を提供しています。

市場セグメンテーションのもう一つの側面は、外来手術センター、病院、専門クリニックを含むエンドユーザーに焦点を当てています。このセグメンテーション戦略の視点により、市場の需要、獲得動向、各エンドユーザー・カテゴリー固有の要件をより深く理解することができます。これらの多様なセグメントの相互作用は、現在の市場力学の全体的な見方に貢献し、技術革新から臨床応用に至るまであらゆる側面が全体的な評価に確実に取り込まれます。この微妙な枠組みは、競合が激しく、急速に進化する情勢の中で戦略を練ろうとする利害関係者にとって不可欠です。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 尿路結石の発生率増加と高齢者人口の増加
    • 非侵襲手術への傾向の高まりと低侵襲技術への意識
    • 病院分野における革新的技術の導入増加
  • 抑制要因
    • 尿路結石治療器具の入手が限られており、コストが高い
  • 機会
    • ポータブルでユーザーフレンドリーな尿路結石症管理デバイスの開発
    • 効果的な尿路結石治療のための低侵襲デバイスの技術的進歩
  • 課題
    • 治療による副作用の可能性に対する懸念
• 市場セグメンテーション分析
  • デバイスタイプ：結石除去における視覚的および機械的性能の優秀性により尿管鏡が好まれる傾向が高まっている
  • 応用：膀胱結石管理における尿路結石症管理デバイスの応用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 尿路結石症管理デバイス市場：デバイスタイプ別

• ガイドワイヤー
• 砕石器
• ステント
• 尿管鏡

第7章 尿路結石症管理デバイス市場治療の種類別

• 体外衝撃波結石破砕術
• 体内結石破砕術
• 経皮的腎結石摘出術

第8章 尿路結石症管理デバイス市場デバイス素材別

• 金属ベースデバイス
• ポリマーベースのデバイス

第9章 尿路結石症管理デバイス市場：用途別

• 膀胱結石
• 腎臓結石
• 尿管結石

第10章 尿路結石症管理デバイス市場：エンドユーザー別

• 外来手術センター
• 病院
• 専門クリニック

第11章 南北アメリカの尿路結石症管理デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の尿路結石症管理デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの尿路結石症管理デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Advanced MedTech Holdings
• AKSM, Ltd.
• Avvio Medical, Inc.
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Calyxo Inc.
• Coloplast A/S
• Cook Group Incorporated
• DirexGroup
• Dornier MedTech GmbH
• Dyne Medical Group Inc.
• E.M.S. Electro Medical Systems S.A.
• EDAP TMS SA
• Elmed Lithotripsy Systems
• EndoTheia, Inc.
• Karl Storz GmbH & Co. KG
• Nissha Medical Technologies
• Olympus Corporation
• Quanta System S.p.A.
• Richard Wolf GmbH
• Siemens Healthineers
• SonoMotion
• Teleflex Incorporated

LIST OF FIGURES

• FIGURE 1. UROLITHIASIS MANAGEMENT DEVICES MARKET MULTI-CURRENCY
• FIGURE 2. UROLITHIASIS MANAGEMENT DEVICES MARKET MULTI-LANGUAGE
• FIGURE 3. UROLITHIASIS MANAGEMENT DEVICES MARKET RESEARCH PROCESS
• FIGURE 4. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. UROLITHIASIS MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. UROLITHIASIS MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. UROLITHIASIS MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. UROLITHIASIS MANAGEMENT DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETEROSCOPES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY METAL-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY POLYMER-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY BLADDER STONES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY KIDNEY STONES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETERAL STONES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 46. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 71. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 73. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 78. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 161. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 162. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 164. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 181. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 182. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 184. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 187. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 189. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 236. UROLITHIASIS MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 237. UROLITHIASIS MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

The Urolithiasis Management Devices Market was valued at USD 490.76 million in 2024 and is projected to grow to USD 527.03 million in 2025, with a CAGR of 7.73%, reaching USD 767.30 million by 2030.

The current landscape of urolithiasis management devices is witnessing an era of rapid innovation and transformative change. In today's healthcare environment, technological advances have led to the development of devices that offer enhanced precision, efficiency, and safety for the treatment of kidney stones, ureteral stones, and bladder stones. This dynamic field blends intricate medical engineering with evolving clinical practices to address one of the most prevalent urinary tract disorders.

Stakeholders including clinicians, biomedical engineers, and hospital administrators are consistently on the lookout for solutions that not only improve patient outcomes but also reduce procedural complications. The integration of advanced imaging, minimally invasive intervention techniques, and improved device ergonomics has dramatically reshaped practices in stone management. This evolution signifies a progressive shift where traditional methods are being supplemented or even replaced by state-of-the-art devices designed to manage urolithiasis through both endoscopic and non-invasive approaches.

In this environment, expert insights and evidence-based data guide decision-making and foster investments in research and development. As innovation continues to disrupt conventional methods, the interplay between clinical efficacy and technological advancements defines the roadmap for future strategies. The opportunity to leverage these improvements for enhanced clinical workflows and patient care is more pronounced than ever, indicating a promising outlook for the market overall.

Transformative Shifts Driving the Urolithiasis Market

Recent years have been marked by transformative shifts that are redefining the urolithiasis management device market. The pace of technological innovation has ushered in devices that are not only more efficient but also safer and easier to use. Innovations have led to improvements in imaging techniques, enhanced navigation capabilities, and real-time feedback mechanisms during surgeries. This evolution has partly been driven by a growing demand for minimally invasive procedures, improved patient comfort, and reduced recovery times.

Regulatory policies have also evolved, facilitating faster market entry for innovative medical devices while ensuring patient safety remains paramount. Collaborative efforts between clinical practitioners and technical experts have fostered the creation of devices that are increasingly tailored to the nuances of urolithiasis treatment. Healthcare providers are now more inclined to adopt technology that integrates seamlessly with existing hospital infrastructure and simplifies complex procedures through automation and digital oversight.

Furthermore, the market is witnessing a gradual shift from traditional surgical methods to digitally-enhanced techniques that incorporate AI-driven diagnostics and procedural guidance. Investment in research and development continues to flow steadily as industries recognize the untapped potential of these novel devices. The transformation in the landscape is underpinned by an evolving ecosystem that blends innovation with practical, evidence-based clinical outcomes. As clinicians and medical device manufacturers work synergistically, the promise of improved therapeutic outcomes combined with cost-efficiency is rapidly becoming a reality.

Deep Dive: Market Segmentation Insights into Device, Treatment, Material, Application, and End Users

A comprehensive analysis of the urolithiasis management device market reveals an intricate segmentation strategy that captures the diversity of the market landscape. The segmentation based on device type dissects the market into segments that include guidewires, lithotripters, stents, and ureteroscopes, each playing a unique role in the treatment protocol. When the market is examined through the lens of treatment type, it is clear that extracorporeal shock wave lithotripsy, intracorporeal lithotripsy, and percutaneous nephrolithotomy are at the forefront of procedural choices, each offering distinct advantages regarding invasiveness and recovery time.

The analysis is further enriched by segmentation based on device material, categorizing the market into metal-based devices and polymer-based devices. This classification helps in understanding performance differences, durability, and patient-specific considerations that underline treatment efficacy. Moreover, by looking at the application-based categorization, the market study addresses conditions pertaining to bladder stones, kidney stones, and ureteral stones, thereby offering a tailored view of therapeutic needs and operational specialties.

Another dimension of market segmentation focuses on the end user, encompassing ambulatory surgical centers, hospitals, and specialty clinics. This perspective of the segmentation strategy allows for a better understanding of market demand, acquisition trends, and the unique requirements of each end user category. The interplay of these diverse segments contributes to a holistic view of current market dynamics, ensuring that every aspect from technological innovation to clinical application is captured in the overall assessment. This nuanced framework is essential for stakeholders looking to strategize in a competitive and rapidly evolving landscape.

Based on Device Type, market is studied across Guidewires, Lithotripters, Stents, and Ureteroscopes.

Based on Treatment Type, market is studied across Extracorporeal Shock Wave Lithotripsy, Intracorporeal Lithotripsy, and Percutaneous Nephrolithotomy.

Based on Device Material, market is studied across Metal-Based Devices and Polymer-Based Devices.

Based on Application, market is studied across Bladder Stones, Kidney Stones, and Ureteral Stones.

Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.

Regional Dynamics Shaping Global and Local Markets

The global distribution of urolithiasis management devices is significantly influenced by varying regional characteristics and healthcare infrastructure maturity. In the Americas, market growth is primarily driven by well-established healthcare systems and an increasing adoption rate of minimally invasive procedures. Regulatory frameworks in the region encourage early adoption of innovative technologies, thereby setting the stage for sustained market growth.

Across Europe, the Middle East, and Africa, there is a noticeable trend towards gradual modernization of healthcare delivery systems. Advanced medical centers, combined with the growing emphasis on patient safety and device efficacy, have markedly contributed to regional market dynamics. Clinical adoption in these regions is enhanced by targeted initiatives aimed at improving patient outcomes and reducing post-procedural complications. The diversity of healthcare systems within these areas presents both challenges and opportunities, requiring tailored strategic responses from manufacturers and service providers.

Meanwhile, the Asia-Pacific region is emerging as one of the fastest-growing markets for urolithiasis management devices. Rising healthcare expenditures, expanding infrastructure, and a surge in medical tourism are key factors driving market evolution. The blend of traditional practices with modern medical innovation creates a fertile ground for advanced device adoption. Furthermore, this region has seen significant improvements in access to specialized healthcare services, facilitating the integration of new technological advancements into current clinical practices. Together, these regional insights underscore a global scenario where local demand, regulatory policies, and infrastructure readiness collectively shape market trajectories.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Innovators in the Urolithiasis Device Sphere

The competitive landscape in the urolithiasis management device market is characterized by contributions from several leading innovators who have significantly influenced both technological advancement and market penetration. Industry pioneers such as Advanced MedTech Holdings have consistently set benchmarks through extensive research and development initiatives. Similarly, companies like AKSM, Ltd. and Avvio Medical, Inc. are making remarkable strides in designing devices that cater to highly specialized clinical requirements, while Becton, Dickinson and Company alongside Boston Scientific Corporation are leveraging their global footprint to drive widespread acceptance of novel treatment methodologies.

Other key players including Calyxo Inc. and Coloplast A/S have focused on enhancing device ergonomics and integrating user-centric functionalities to ensure seamless operation during surgical procedures. Cook Group Incorporated and DirexGroup bring a strategic blend of technological innovation and robust distribution networks that position them as reliable partners in the market. Additionally, Dornier MedTech GmbH, Dyne Medical Group Inc., and E.M.S. Electro Medical Systems S.A. have been pivotal in pushing the boundaries of device precision and patient safety.

EDAP TMS SA, Elmed Lithotripsy Systems, EndoTheia, Inc., and Karl Storz GmbH & Co. KG are also at the forefront of transformative developments in this sector. The contributions from innovators such as Nissha Medical Technologies, Olympus Corporation, Quanta System S.p.A., Richard Wolf GmbH, Siemens Healthineers, SonoMotion, and Teleflex Incorporated illustrate the market's evolving nature. Each of these companies has embraced a forward-thinking approach that not only enhances device functionality but also aligns with the latest trends in patient-centered care. Their collective efforts have led to significant improvements in device reliability, user experience, and clinical outcomes, positioning the industry for long-term growth.

The report delves into recent significant developments in the Urolithiasis Management Devices Market, highlighting leading vendors and their innovative profiles. These include Advanced MedTech Holdings, AKSM, Ltd., Avvio Medical, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Calyxo Inc., Coloplast A/S, Cook Group Incorporated, DirexGroup, Dornier MedTech GmbH, Dyne Medical Group Inc., E.M.S. Electro Medical Systems S.A., EDAP TMS SA, Elmed Lithotripsy Systems, EndoTheia, Inc., Karl Storz GmbH & Co. KG, Nissha Medical Technologies, Olympus Corporation, Quanta System S.p.A., Richard Wolf GmbH, Siemens Healthineers, SonoMotion, and Teleflex Incorporated. Guiding Strategic Recommendations for Market Excellence

Industry stakeholders need to adopt a multi-faceted strategy to maintain a competitive edge in the evolving market of urolithiasis management devices. One of the first actionable recommendations is to ensure ongoing investment in research and development, particularly in areas that enhance device precision and improve patient safety. Stakeholders should collaborate closely with clinical research bodies to ensure that new products not only meet regulatory standards but also align with the evolving needs of the healthcare market.

Another key recommendation is to strengthen partnerships across the value chain, ranging from raw material suppliers to healthcare practitioners who deploy these devices in clinical settings. Effective collaboration can facilitate the integration of digital technologies and analytics, allowing companies to streamline operations and develop devices that deliver both cost efficiency and enhanced procedural outcomes. It is also advisable for manufacturers to remain agile in response to regional variations in market dynamics; tailoring strategies for different geographies by understanding local regulatory environments, healthcare priorities, and patient demographics can yield significant competitive advantages.

Moreover, companies should focus on training and support programs that empower clinical teams to fully leverage the benefits of advanced urolithiasis management technology. Emphasizing continuous education, workshops, and real-world case demonstrations can boost confidence among users and accelerate the adoption curve. Strategic investments in digital marketing and thought leadership are also critical in establishing a strong brand presence and influencing decision-makers in the healthcare sector. By adopting these recommendations, industry leaders can not only secure their market position but also drive transformative changes that resonate across clinical practices worldwide.

Concluding Reflections on Market Trends and Future Prospects

In conclusion, the current market for urolithiasis management devices is set on a promising path, driven by significant technological advancements and an increasing emphasis on minimally invasive procedures. The strategic integration of innovations, ranging from advanced imaging to digital analytics, has fundamentally altered the approach to managing urolithiasis. As stakeholders navigate this dynamic environment, a deep understanding of market segmentation, regional dynamics, and competitive forces remains critical.

The insights gathered from both qualitative and quantitative analyses suggest that market players must continue to invest in product development and embrace collaborative partnerships to meet the rising expectations of healthcare providers. The future of urolithiasis management is not solely reliant on isolated technological innovations but also on the seamless integration of these advancements within existing clinical infrastructures. As global healthcare demands evolve, businesses that maintain a patient-centric approach, focus on reliability, and adapt swiftly to market changes are likely to thrive.

The continuous evolution in this industry will undoubtedly usher in further developments that may set new standards for efficiency and efficacy in patient care. As medical professionals, researchers, and device manufacturers build on the current momentum, the overall impact on patient outcomes could be transformative. Ultimately, the convergence of innovation, strategic investments, and a comprehensive understanding of market dynamics will drive the future success and sustainability of the urolithiasis management device sector.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of urinary stones and increasing elderly population
    • 5.1.1.2. Rising proclivity for non-invasive surgeries and awareness of minimally invasive techniques
    • 5.1.1.3. Increasing adoption of innovative technologies in the hospital sector
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability and high cost of urolithiasis devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of portable and user-friendly urolithiasis management devices
    • 5.1.3.2. Technological advancements in minimally invasive devices for effective urolithiasis treatment
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns over probable side effects of the treatment
• 5.2. Market Segmentation Analysis
  • 5.2.1. Device Type: Rising preference for ureteroscopes owing to visual and mechanical excellence in stone extraction
  • 5.2.2. Application: Expanding application of urolithiasis management devices for bladder stone management
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Urolithiasis Management Devices Market, by Device Type

• 6.1. Introduction
• 6.2. Guidewires
• 6.3. Lithotripters
• 6.4. Stents
• 6.5. Ureteroscopes

7. Urolithiasis Management Devices Market, by Treatment Type

• 7.1. Introduction
• 7.2. Extracorporeal Shock Wave Lithotripsy
• 7.3. Intracorporeal Lithotripsy
• 7.4. Percutaneous Nephrolithotomy

8. Urolithiasis Management Devices Market, by Device Material

• 8.1. Introduction
• 8.2. Metal-Based Devices
• 8.3. Polymer-Based Devices

9. Urolithiasis Management Devices Market, by Application

• 9.1. Introduction
• 9.2. Bladder Stones
• 9.3. Kidney Stones
• 9.4. Ureteral Stones

10. Urolithiasis Management Devices Market, by End User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Hospitals
• 10.4. Specialty Clinics

11. Americas Urolithiasis Management Devices Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Urolithiasis Management Devices Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Urolithiasis Management Devices Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Nissha and Endotheia unveil FlexStone Basket, enhancing kidney stone removal through innovation and collaboration
  • 14.3.2. FDA de novo clearance granted to Stone Clear, a non-invasive device for managing post-lithotripsy kidney stones and reducing relapse risk
  • 14.3.3. Olympus enhances urolithiasis management with FDA-cleared RenaFlex single-use flexible ureteroscope
  • 14.3.4. Calyxo receives FDA approval for redesign of device that collects kidney stone fragments
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advanced MedTech Holdings
• 2. AKSM, Ltd.
• 3. Avvio Medical, Inc.
• 4. Becton, Dickinson and Company
• 5. Boston Scientific Corporation
• 6. Calyxo Inc.
• 7. Coloplast A/S
• 8. Cook Group Incorporated
• 9. DirexGroup
• 10. Dornier MedTech GmbH
• 11. Dyne Medical Group Inc.
• 12. E.M.S. Electro Medical Systems S.A.
• 13. EDAP TMS SA
• 14. Elmed Lithotripsy Systems
• 15. EndoTheia, Inc.
• 16. Karl Storz GmbH & Co. KG
• 17. Nissha Medical Technologies
• 18. Olympus Corporation
• 19. Quanta System S.p.A.
• 20. Richard Wolf GmbH
• 21. Siemens Healthineers
• 22. SonoMotion
• 23. Teleflex Incorporated